Shane William Charles Kovacs

Shane William Charles Kovacs is a declared insider at 2 companies; the most frequent names are Olema Pharmaceuticals, Inc. and PTC Therapeutics, Inc. The record holds 26 filings, for trades running from 22 May 2014 to 15 January 2026.

Both buying and selling appear: 2 purchases, against 11 sales worth €7.2M. The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 share grants and 7 option exercises. So far in 2026, the count stands at no purchases and 2 sales.

The record was last updated on 15 January 2026 with an open-market sale (€2.5M) in Olema Pharmaceuticals, Inc. The clock since the last published purchase (7 April 2023) now reads 1,296 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.